文献速递基础与转化研究流行病学与生物统计组学、生物样本库与精准医学

多性状关联引导的2型糖尿病遗传位点软聚类分析揭示疾病机制与亚型

Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.
PubMed 文献 · PLoS Med · 2018-09-21

研究采用贝叶斯非负矩阵分解(bNMF)聚类方法,对94个独立2型糖尿病(T2D)遗传变异和47个糖尿病相关性状的GWAS结果进行分析,识别出5个稳健的遗传位点-性状聚类,分别反映β细胞功能降低(高/低胰岛素原水平)和三种胰岛素抵抗特征。这些聚类的遗传风险评分与血压升高、冠心病和卒中等不同临床结局相关,且在四个T2D研究子集中可重复展示聚类相关表型。

要点

  • 基于94个T2D遗传变异和47个性状的聚类分析识别出5个机制不同的遗传亚群。
  • 两个聚类反映β细胞功能降低(高/低胰岛素原水平),三个反映胰岛素抵抗的不同特征。
  • 各聚类遗传风险评分与血压、冠心病、卒中等不同临床结局相关,且可在多个T2D子集中重复。

核心结论

  • 基于生理学的遗传聚类方法可识别T2D的显著遗传锚定通路,支持利用遗传学解构T2D异质性。
  • 按这些遗传通路对患者分类可能为遗传信息指导的T2D患者管理迈出一步。

研究设计与样本

  • 研究应用贝叶斯非负矩阵分解(bNMF)聚类于94个独立T2D遗传变异和47个糖尿病相关性状的GWAS结果。
  • 利用28种细胞类型的表观基因组数据分析各聚类的组织特异性增强子富集。
  • 在四个含T2D个体的研究(METSIM N=487;Ashkenazi N=509;Partners Biobank N=2,065;UK Biobank N=14,813)中评估聚类遗传风险评分的临床后果。

主要发现

  • 识别出五个稳健的T2D位点与性状聚类,各具基于28种细胞类型表观基因组数据的独特组织特异性增强子富集。
  • 两个聚类包含提示β细胞功能降低的变异-性状关联,区别在于胰岛素原水平高或低。
  • 三个聚类显示胰岛素抵抗特征:肥胖介导(高BMI和腰围)、「脂肪营养不良样」脂肪分布(低BMI、脂联素和HDL胆固醇,高甘油三酯)及肝脏脂质代谢紊乱(低甘油三酯)。
  • 聚类遗传风险评分升高与不同临床结局相关,包括血压升高、冠心病(CAD)和卒中。
  • 在四个T2D研究子集中,各聚类遗传风险评分最高十分位的个体可重复表现出预期的聚类相关表型,约30%的所有个体仅被分配至一个聚类的最高十分位。

关键数值与推荐

  • 聚类分析所用遗传变异仅限于在欧洲血统人群中与T2D相关的变异。

临床怎么用

  • 基于遗传通路的患者分类可能为遗传信息指导的T2D患者管理提供新途径。

局限性

  • 聚类分析所用的遗传变异仅限于欧洲血统人群中与T2D相关的变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type 2 diabetes (T2D) is a heterogeneous disease for which (1) disease-causing pathways are incompletely understood and (2) subclassification may improve patient management. Unlike other biomarkers, germline genetic markers do not change with disease progression or treatment. In this paper, we test whether a germline genetic approach informed by physiology can be used to deconstruct T2D heterogeneity. First, we aimed to categorize genetic loci into groups representing likely disease mechanistic pathways. Second, we asked whether the novel clusters of genetic loci we identified have any broad clinical consequence, as assessed in four separate subsets of individuals with T2D. METHODS AND FINDINGS: In an effort to identify mechanistic pathways driven by established T2D genetic loci, we applied Bayesian nonnegative matrix factorization (bNMF) clustering to genome-wide association study (GWAS) results for 94 independent T2D genetic variants and 47 diabetes-related traits. We identified five robust clusters of T2D loci and traits, each with distinct tissue-specific enhancer enrichment based on analysis of epigenomic data from 28 cell types. Two clusters contained variant-trait associations indicative of reduced beta cell function, differing from each other by high versus low proinsulin levels. The three other clusters displayed features of insulin resistance: obesity mediated (high body mass index [BMI] and waist circumference [WC]), "lipodystrophy-like" fat distribution (low BMI, adiponectin, and high-density lipoprotein [HDL] cholesterol, and high triglycerides), and disrupted liver lipid metabolism (low triglycerides). Increased cluster genetic risk scores were associated with distinct clinical outcomes, including increased blood pressure, coronary artery disease (CAD), and stroke. We evaluated the potential for clinical impact of these clusters in four studies containing individuals with T2D (Metabolic Syndrome in Men Study [METSIM], N = 487; Ashkenazi, N = 509; Partners Biobank, N = 2,065; UK Biobank [UKBB], N = 14,813). Individuals with T2D in the top genetic risk score decile for each cluster reproducibly exhibited the predicted cluster-associated phenotypes, with approximately 30% of all individuals assigned to just one cluster top decile. Limitations of this study include that the genetic variants used in the cluster analysis were restricted to those associated with T2D in populations of European ancestry. CONCLUSION: Our approach identifies salient T2D genetically anchored and physiologically informed pathways, and supports the use of genetics to deconstruct T2D heterogeneity. Classification of patients by these genetic pathways may offer a step toward genetically informed T2D patient management.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Udler MS, Kim J, von Grotthuss M, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med. 2018. PMID: 30240442. doi:10.1371/journal.pmed.1002654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。